The Decision Guide to Breast Reconstruction
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Breast Reconstruction Surgery for Mastectomy in Hospital Inpatient and Ambulatory Settings, 2009–2014
HEALTHCARE COST AND Agency for Healthcare UTILIZATION PROJECT Research and Quality STATISTICAL BRIEF #228 October 2017 Highlights Breast Reconstruction Surgery for ■ From 2009 to 2014, in 22 Mastectomy in Hospital Inpatient and States, the population rate of Ambulatory Settings, 2009–2014 breast reconstruction for mastectomy increased by 62 Adela M. Miller, B.S., Claudia A. Steiner, M.D., M.P.H., percent, from 21.7 to 35.1 per Marguerite L. Barrett, M.S., Kathryn R. Fingar, Ph.D., M.P.H., 100,000 women aged 18 years and Anne Elixhauser, Ph.D. or older. ■ Increases occurred for all age Introduction groups, but disproportionately so for women aged 65 years After a mastectomy (surgical removal of the breast), a woman and older, those covered by faces a complex and emotional decision about whether to have Medicare, and those who were breast reconstruction or live without a breast or breasts. There uninsured. are usually three main considerations in the decision: medical, sexual, and physical. Medical considerations include concerns ■ In 2014, women who lived in that breast reconstruction surgery lengthens recovery time and rural areas had fewer increases the chance for infection and other postoperative reconstructions (29 per 100 complications. Sexual considerations involve the impact of the mastectomies) compared with mastectomy on future sexual encounters. Physical features urban-dwelling women (41 include how breasts may define femininity and sense of self.1 reconstructions per 100 mastectomies). Several previous studies have shown an increase in breast ■ Growth in breast reconstructive 2,3,4 reconstruction for mastectomy. One study used a 2007 surgery was primarily national surgical database, another study used 2008 claims-based attributable to the following data of women insured through large private employers, and a factors: third study used the Nationwide Inpatient Sample (NIS) for 2005– 2011,5,6,7 part of the Healthcare Cost and Utilization Project o Ambulatory surgeries (HCUP) increased more than 150 percent. -
Breast Reconstruction with Expanders and Implants
Evidence-Based Clinical Practice Guideline: Breast Reconstruction with Expanders and Implants INTRODUCTION Disclaimer Evidence-based guidelines are strategies for patient management, The American Cancer Society estimates that nearly 230,000 American developed to assist physicians in clinical decision making. This women were diagnosed with invasive breast cancer in 2011.1 Many of guideline was developed through a comprehensive review of the these individuals will require mastectomy and total reconstruction of scientific literature and consideration of relevant clinical experience, the breast. The diagnosis and subsequent process can create signifi- and describes a range of generally acceptable approaches to diagnosis, cant confusion and distress for the affected persons and their families management, or prevention of specific diseases or conditions. This and, consequently, surgical treatment and reconstructive procedures guideline attempts to define principles of practice that should are of utmost importance in the breast cancer care continuum. In generally meet the needs of most patients in most circumstances. 2011, the American Society of Plastic Surgeons® (ASPS) reported an increase in the rate of breast reconstructions, citing nearly 100,000 However, this guideline should not be construed as a rule, nor procedures, of which the majority employed expanders/implants.2 should it be deemed inclusive of all proper methods of care The 3% increase in reconstructions over the course of just one year or exclusive of other methods of care reasonably directed at highlights the significance of maintaining patient safety and obtaining the appropriate results. It is anticipated that it will be optimizing surgical outcomes. necessary to approach some patients’ needs in different ways. -
ASPS Clinical Practice Guideline Summary on Breast Reconstruction with Expanders and Implants
CME ASPS Clinical Practice Guideline Summary on Breast Reconstruction with Expanders and Implants Amy Alderman, M.D., M.P.H. Learning Objectives: After reading this article, participants should be able to: Karol Gutowski, M.D. 1. Understand the evidence regarding the timing of expander/implant breast re- Amy Ahuja, M.P.H. construction in the setting of radiation therapy. 2. Discuss the implications of a Diedra Gray, M.P.H. patient’s risk factors for possible outcomes and complications of expander/implant Postmastectomy breast reconstruction. 3. Implement proper prophylactic antibiotic protocols. 4. Use Expander/Implant Breast the guidelines to improve their own clinical outcomes and reduce complications. Reconstruction Guideline Summary: In March of 2013, the Executive Committee of the American Society Work Group of Plastic Surgeons approved an evidence-based guideline on breast reconstruc- Arlington Heights, Ill. tion with expanders and implants, as developed by a guideline-specific work group commissioned by the society’s Health Policy Committee. The guideline addresses ten clinical questions: patient education, immediate versus delayed reconstruction, risk factors, radiation therapy, chemotherapy, hormonal therapy, antibiotic prophylaxis, acellular dermal matrix, monitoring for cancer recur- rence, and oncologic outcomes associated with implant-based reconstruction. The evidence indicates that patients undergoing mastectomy should be offered a preoperative referral to a plastic surgeon. Evidence varies regarding the as- sociation between postoperative complications and timing of postmastectomy expander/implant breast reconstruction. Evidence is limited regarding the opti- mal timing of expand/implant reconstruction in the setting of radiation therapy but suggests that irradiation to the expander or implant is associated with an increased risk of postoperative complications. -
Silicone-Filled Breast Implants
Important Information for Women About Breast Reconstruction with INAMED® Silicone-Filled Breast Implants RECON Patient Labeling Rev 11/03/06/06 page 1 TABLE OF CONTENTS Page GLOSSARY ..................................................................................................................................... 4 1. CONSIDERING SILICONE GEL-FILLED BREAST IMPLANT SURGERY ............................ 10 1.1 WHAT GIVES THE BREAST ITS SHAPE? ...................................................................... 11 1.2 WHAT IS A SILICONE GEL-FILLED BREAST IMPLANT? .............................................. 11 1.3 ARE SILICONE GEL-FILLED BREAST IMPLANTS RIGHT FOR YOU? ......................... 12 1.4 IMPORTANT FACTORS YOU SHOULD CONSIDER IN CHOOSING SILICONE GEL-FILLED BREAST IMPLANTS ................................................................. 12 2. BREAST IMPLANT COMPLICATIONS................................................................................... 14 2.1 WHAT ARE THE POTENTIAL COMPLICATIONS? ......................................................... 14 2.2 WHAT ARE OTHER REPORTED CONDITIONS? ........................................................... 19 3. ALLERGAN* CORE STUDY RESULTS .................................................................................. 22 3.1 OVERVIEW OF ALLERGAN’S CORE STUDY................................................................. 22 3.2 WHAT WERE THE 4-YEAR FOLLOW-UP RATES? ........................................................ 22 3.3 WHAT WERE THE BENEFITS? ...................................................................................... -
310-C, Breast Reconstruction After Mastectomy
AHCCCS MEDICAL POLICY MANUAL SECTION 310– COVERED SERVICES 310-C - BREAST RECONSTRUCTION AFTER MASTECTOMY EFFECTIVE DATES: 10/01/94, 11/27/18 REVISION DATES: 10/01/99, 10/01/01, 05/01/06, 10/01/06, 01/01/11, 09/27/18 I. PURPOSE This Policy applies to AHCCCS Complete Care (ACC), ALTCS E/PD, DCS/CMDP (CMDP), DES/DDD (DDD), and RBHA Contractors; Fee-For-Service (FFS) Programs as delineated within this Policy including: Tribal ALTCS, the American Indian Health Program (AIHP); and all FFS populations, excluding Federal Emergency Services (FES). (For FES, see AMPM Chapter 1100). This Policy establishes requirements for breast reconstruction surgery following a Mastectomy. II. DEFINITIONS MASTECTOMY Removal of the entire breast through surgery. III. POLICY Breast reconstruction surgery for the purposes of breast reconstruction post-mastectomy is a covered service if the member is AHCCCS eligible. The member may elect to have breast reconstruction surgery immediately following the Mastectomy or may choose to delay breast reconstruction; however, the member shall be AHCCCS eligible at the time of breast reconstruction surgery. The type of breast reconstruction performed is determined by the physician in consultation with the member. A. COVERAGE POLICIES FOR BREAST RECONSTRUCTIVE SURGERY 1. Reconstruction of the affected and the contralateral unaffected breast following a medically necessary Mastectomy is considered an effective non-cosmetic procedure. Breast reconstruction surgery following Mastectomy for any medical reason is a covered service. 2. Medically necessary breast implant removal is a covered service. Replacement of breast implants is a covered service when the original implant was the result of a medically necessary Mastectomy. -
Your Options a Guide to Reconstruction for Breast Cancer
Your Options A Guide to Reconstruction for Breast Cancer Options In this booklet Introduction to Breast Reconstruction ................................................................ 3 How to Make a Decision .............................................................................. 4 UMHS Team .......................................................................................... 6 Reconstruction Options Implants ........................................................................................... 7 Natural Tissue and Implants ....................................................................... 10 Lat Dorsi (Latissimus Dorsi) Flap Natural Tissue Reconstruction .................................................................... 11 Abdomen • Pedicled TRAM (Transverse Rectus Abdominis Myocutaneous) Flap • Free TRAM (Transverse Rectus Abdominis Myocutaneous) Flap • Free Muscle-Sparing TRAM (Transverse Rectus Abdominis Myocutaneous) Flap • Free DIEP (Deep Inferior Epigastric Perforator) Flap • Free SIEA (Superficial Inferior Epigastric Artery) Flap Alternative Donor Sites ........................................................................... 15 SGAP (Superior Gluteal Artery Perforator) Flap TUG (Transverse Upper Gracilis) Flap Additional Surgeries After Reconstruction ........................................................ 17 • Nipple Reconstruction • Breast Lift, Augmentation, Reduction Terms to Know .................................................................................... 19 “I’m a wife and mother and I -
Breast Implant Illness - Frequently Asked Questions/Talking Points
Breast Implant Illness - Frequently Asked Questions/Talking Points Q: What is Breast Implant Illness (BII)? A: There are women with breast implants who self-identify and present with various systemic symptoms and believe that these are related to their breast implants. They refer to these symptoms as Breast Implant Illness (BII). Breast Implant Illness (BII) is a term used by women who have breast implants and who self- identify and describe a variety of symptoms including (but not limited to) fatigue, chest pain, hair loss, headaches, chills, photosensitivity, chronic pain, rash, body odor, anxiety, brain fog, sleep disturbance, depression, neurologic issues and hormonal issues that they feel are directly connected to their saline or silicone, textured or smooth breast implants. The recent increase in patients reporting Breast Implant Illness (BII) symptoms appears to be related to social media. There is one Facebook group alone with more than 50,000 members, all of whom report Breast Implant Illness (BII) symptoms. This is not to say that social media is the cause of Breast Implant Illness (BII) however, it may account for the rapid increases in patient reporting. BII is not an official medical diagnosis. Q: Is there a link between medical grade silicone implants and any disease? A: Silicone is an element that exists in nature as crystalline silica, which has been shown to activate the immune system in conditions such as systemic sclerosis which has been seen in stone masons. Silicone used in breast implants is different and to date has not been proven to cause any disease. This silicone does not exist is nature, it is created by hydroxylating silica to form polydimethylsiloxane. -
Breast Augmentation Surgery: Clinical Considerations
REVIEW DEMETRIUS M. COOMBS, MD RITWIK GROVER, MD ALEXANDRE PRASSINOS, MD RAFFI GURUNLUOGLU, MD, PhD Department of Plastic Surgery, Department of Plastic Surgery, Division of Plastic and Reconstructive Department of Plastic Surgery, Dermatology and Dermatology and Plastic Surgery Institute, Dermatology and Plastic Surgery Surgery, Department of Surgey, Plastic Surgery Institute, Cleveland Clinic; Profes- Cleveland Clinic Institute, Cleveland Clinic Yale School of Medicine, New Haven, CT sor, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH Breast augmentation surgery: Clinical considerations ABSTRACT t present, 300,000 US women undergo Abreast augmentation surgery each year,1 Women receive breast implants for both aesthetic and making this the second most common aes- reconstructive reasons. This brief review discusses the thetic procedure in women (after liposuc- evolution of and complications related to breast implants, tion),2–4 and making it extremely likely that as well as key considerations with regard to aesthetic clinicians will encounter women who have and reconstructive surgery of the breast. breast implants. In addition, approximately 110,000 women undergo breast reconstruc- KEY POINTS tive surgery after mastectomy, of whom more Nearly 300,000 breast augmentation surgeries are per- than 88,000 (81%) receive implants (2016 5 formed annually, making this the second most common data). aesthetic procedure in US women (after liposuction). This review discusses the evolution of breast implants, their complications, and key considerations with regard to aesthetic and Today, silicone gel implants dominate the world market, reconstructive breast surgery, as the principles and in the United States, approximately 60% of implants are similar. contain silicone gel fi ller. -
Case Complexity Banding 2020
Case Complexity Banding 2020 Issue date: February 2020 Complexity 1 Complexity 2 Complexity 3 Complexity 4 Complexity 5 Complexity 6 Two complexity Three complexity 1 specimens Four or more complexity Cases sent for a specialist Samples of 20 slides Applicable to 1 specimens 1 specimens second opinion or greater all Specialities Two complexity 2 specimens Three complexity 2 specimens Wet specimen X-Ray Ligament biopsy Bursa Joint biopsy Bone - benign (small) Bone - benign (large) Bone biopsy Bone, Joint and Osteo Ligament cyst Cartilage Femoral head Digit amputation Bone tumour resection (local) Tendon biopsy Synovial biopsy Tendon Vertebrae Vertebral disc Breast reduction Breast implant capsule Axillary clearance Excision biopsy with shave Bilateral mastectomy Breast excision & axillary clearance Excision biopsy Cavity shave WLE with shave excision Mastectomy - malignant & axillary clearance Mastectomy scar Needlecore biopsy (2 specimens) Needle/wire guided excision Microdochectomy Wide Local Excision Needlecore biopsy (WLE) +/- axillary clearance Nipple biopsy Artery Mitral valve Aortic valve Heart transplant Cardio Aortic valve biopsy Heart valve Parathyroid - one specimen Adrenal – benign Adrenal - malignant Endocrine Thyroid biopsy Parathyroid -– Parathyroid – malignant 2 or more specimens Pituitary – malignant Pituitary – benign Thyroid -– malignant Thyroid - benign CUST-DOC-1 Version 7.0 Complexity 1 Complexity 2 Complexity 3 Complexity 4 Complexity 5 Complexity 6 Anal fistula Colonic donut Biopsy/polyp (1-3 specimens)* Biopsy/polyp -
Breast Reconstruction with Radiation Therapy
Understanding Risks and Side Effects of Breast Reconstruction with Radiation Therapy One of the most important goals of Moffitt Cancer Center is to provide you with quality patient care through education, research and service. Your breast surgeon may have mentioned the option of breast reconstruction. Before you decide if reconstruction is right for you, please review the following information. This sheet explains the risks and side effects of breast reconstruction with radiation therapy: • when you already have a breast implant in place prior to your treatment for cancer. • or when your doctor recommends radiation therapy after reconstruction. Your breast surgeon may refer you to the Plastic Surgeon and the Radiation Oncologist to discuss your individual situation and to address questions and concerns regarding reconstruction and radiation therapy. For most women, breast cancer involves surgery. One type, called breast conservation therapy , allows the woman to keep her natural or implanted breast by having only the portion of the breast affected with cancer removed. This type of breast conservation surgery is called lumpectomy or partial mastectomy. After a lumpectomy, radiation therapy is used to destroy any cancer cells left behind after surgery. Women who have had breast augmentation , or implants placed to change the size and appearance of the breast, have the following risks to consider. Breast Conservation Therapy : Risks with Existing Implants Breast conservation therapy can cause scar tissue in the breast, resulting in a noticeable difference in the shape and size of the breasts in a large percentage of patients. This difference is called asymmetry. Many women have breasts that do not match in size or shape prior to surgery. -
Icd-9-Cm (2010)
ICD-9-CM (2010) PROCEDURE CODE LONG DESCRIPTION SHORT DESCRIPTION 0001 Therapeutic ultrasound of vessels of head and neck Ther ult head & neck ves 0002 Therapeutic ultrasound of heart Ther ultrasound of heart 0003 Therapeutic ultrasound of peripheral vascular vessels Ther ult peripheral ves 0009 Other therapeutic ultrasound Other therapeutic ultsnd 0010 Implantation of chemotherapeutic agent Implant chemothera agent 0011 Infusion of drotrecogin alfa (activated) Infus drotrecogin alfa 0012 Administration of inhaled nitric oxide Adm inhal nitric oxide 0013 Injection or infusion of nesiritide Inject/infus nesiritide 0014 Injection or infusion of oxazolidinone class of antibiotics Injection oxazolidinone 0015 High-dose infusion interleukin-2 [IL-2] High-dose infusion IL-2 0016 Pressurized treatment of venous bypass graft [conduit] with pharmaceutical substance Pressurized treat graft 0017 Infusion of vasopressor agent Infusion of vasopressor 0018 Infusion of immunosuppressive antibody therapy Infus immunosup antibody 0019 Disruption of blood brain barrier via infusion [BBBD] BBBD via infusion 0021 Intravascular imaging of extracranial cerebral vessels IVUS extracran cereb ves 0022 Intravascular imaging of intrathoracic vessels IVUS intrathoracic ves 0023 Intravascular imaging of peripheral vessels IVUS peripheral vessels 0024 Intravascular imaging of coronary vessels IVUS coronary vessels 0025 Intravascular imaging of renal vessels IVUS renal vessels 0028 Intravascular imaging, other specified vessel(s) Intravascul imaging NEC 0029 Intravascular -
Medical Policy Breast Surgeries
Medical Policy Breast Surgeries Subject: Breast Surgeries Authorization: Prior authorization is required for breast surgery procedures requested for members enrolled in HPHC commercial (HMO, POS, or PPO) products. Prior authorization is not required for mastectomy procedures including prophylactic mastectomy. This policy utilizes InterQual® criteria and/or tools, which Harvard Pilgrim may have customized. You may request authorization and complete the automated authorization questionnaire via HPHConnect at www.harvardpilgrim.org/providerportal. In some cases, clinical documentation and/or color photographs may be required to complete a medical necessity review. Please submit required documentation as follows: • Clinical notes/written documentation —via HPHConnect Clinical Upload or secure fax (800-232-0816) • Photographs— HPHConnect Clinical Upload function, email ([email protected]), or mail (Utilization Management, 1600 Crown Colony Dr., Quincy, MA 02169). Please note that photographs should not be faxed as faxed photos cannot be utilized in making a medical necessity determination. Providers may view and print the medical necessity criteria and questionnaire via HPHConnect for providers (Select Resources and the InterQual® link) or contact the commercial Provider Service Center at 800-708-4414. (To register for HPHConnect, follow the instructions here.) Members may access these materials by logging into their online account (visit www.harvardpilgrim.org, click on Member Login, then Plan Details, Prior Authorization